参考文献:1.Delcourt C, Huang Y, Arima H, INTERACT1 Investigators, et al. Hematoma growth and outcomes in intracerebral hemorrhage: the INTERACT1 study. Neurology. 2012;79:314鈥?.CrossRef PubMed 2.Vermeer SE, Algra A, Franke CL, Koudstaal PJ, Rinkel GJ. Long-term prognosis after recovery from primary intracerebral hemorrhage. Neurology. 2002;59:205鈥?.CrossRef PubMed 3.Brott T, Broderick J, Kothari R, et al. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke. 1997;28:1鈥?.CrossRef PubMed 4.Leira R, D谩valos A, Silva Y, et al. Stroke Project, Cerebrovascular Diseases Group of the Spanish Neurological Society. Early neurologic deterioration in intracerebral hemorrhage: predictors and associated factors. Neurology. 2004;63:461鈥?.CrossRef PubMed 5.Mayer SA, Brun NC, Begtrup K, Recombinant Activated Factor VII Intracerebral Hemorrhage Trial Investigators, et al. Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2005;352:777鈥?5.CrossRef PubMed 6.Mayer SA, Brun NC, Begtrup K, FAST Trial Investigators, et al. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2008;358:2127鈥?7.CrossRef PubMed 7.Goldstein JN, Fazen LE, Snider R, et al. Contrast extravasation on CT angiography predicts hematoma expansion in intracerebral hemorrhage. Neurology. 2007;68:889鈥?4.CrossRef PubMed 8.Demchuk AM, Dowlatshahi D, Rodriguez-Luna D, et al. PREDICT/Sunnybrook ICH CTA study group. Prediction of haematoma growth and outcome in patients with intracerebral haemorrhage using the CT-angiography spot sign (PREDICT): a prospective observational study. Lancet Neurol. 2012;11:307鈥?4.CrossRef PubMed 9.Brouwers HB, Chang Y, Falcone GJ, et al. Predicting hematoma expansion after primary intracerebral hemorrhage. JAMA Neurol. 2014;71:158鈥?4.PubMed Central CrossRef PubMed 10.Iasonos A, Schrag D, Raj GV, Panageas KS. How to build and interpret a nomogram for cancer prognosis. J Clin Oncol. 2008;26:1364鈥?0.CrossRef PubMed 11.Kattan MW. Nomograms are superior to staging and risk grouping systems for identifying high-risk patients: preoperative application in prostate cancer. Curr Opin Urol. 2003;13:111鈥?.CrossRef PubMed 12.Shariat SF, Karakiewicz PI, Suardi N, Kattan MW. Comparison of nomograms with other methods for predicting outcomes in prostate cancer: a critical analysis of the literature. Clin Cancer Res. 2008;14:4400鈥?.CrossRef PubMed 13.Toyoda K, Okada Y, Minematsu K, et al. Antiplatelet therapy contributes to acute deterioration of intracerebral hemorrhage. Neurology. 2005;65:1000鈥?.CrossRef PubMed 14.Kazui S, Naritomi H, Yamamoto H, Sawada T, Yamaguchi T. Enlargement of spontaneous intracerebral hemorrhage. Incidence and time course. Stroke. 1996;27:1783鈥?.CrossRef PubMed 15.Hussein HM, Tariq NA, Palesch YY, Qureshi AI, ATACH Investigators. Reliability of hematoma volume measurement at local sites in a multicenter acute intracerebral hemorrhage clinical trial. Stroke. 2013;44:237鈥?.PubMed Central CrossRef PubMed 16.Romero JM, Brouwers HB, Lu J, et al. Prospective validation of the computed tomographic angiography spot sign score for intracerebral hemorrhage. Stroke. 2013;44:3097鈥?02.PubMed Central CrossRef PubMed 17.Brouwers HB, Biffi A, Ayres AM, et al. Apolipoprotein E genotype predicts hematoma expansion in lobar intracerebral hemorrhage. Stroke. 2012;43:1490鈥?.PubMed Central CrossRef PubMed 18.Barras CD, Tress BM, Christensen S, Recombinant Activated Factor VII Intracerebral Hemorrhage Trial Investigators, et al. Density and shape as CT predictors of intracerebral hemorrhage growth. Stroke. 2009;40:1325鈥?1.CrossRef PubMed 19.Dowlatshahi D, Smith EE, Flaherty ML, Ali M, Lyden P, Demchuk AM, VISTA Collaborators. Small intracerebral haemorrhages are associated with less haematoma expansion and better outcomes. Int J Stroke. 2011;6:201鈥?.CrossRef PubMed 20.Cucchiara B, Messe S, Sansing L, Kasner S, Lyden P, CHANT Investigators. Hematoma growth in oral anticoagulant related intracerebral hemorrhage. Stroke. 2008;39:2993鈥?.CrossRef PubMed 21.Broderick JP, Diringer MN, Hill MD, Recombinant Activated Factor VII Intracerebral Hemorrhage Trial Investigators, et al. Determinants of intracerebral hemorrhage growth: an exploratory analysis. Stroke. 2007;38:1072鈥?.CrossRef PubMed 22.Maruishi M, Shima T, Okada Y, Nishida M, Yamane K. Involvement of fluctuating high blood pressure in the enlargement of spontaneous intracerebral hematoma. Neurol Med Chir (Tokyo). 2001;41:300鈥?.CrossRef 23.Fujii Y, Takeuchi S, Sasaki O, Minakawa T, Tanaka R. Multivariate analysis of predictors of hematoma enlargement in spontaneous intracerebral hemorrhage. Stroke. 1998;29:1160鈥?.CrossRef PubMed 24.Rodriguez-Luna D, Pi帽eiro S, Rubiera M, et al. Impact of blood pressure changes and course on hematoma growth in acute intracerebral hemorrhage. Eur J Neurol. 2013;20:1277鈥?3.CrossRef PubMed 25.Takeda R, Ogura T, Ooigawa H, et al. A practical prediction model for early hematoma expansion in spontaneous deep ganglionic intracerebral hemorrhage. Clin Neurol Neurosurg. 2013;115:1028鈥?1.CrossRef PubMed 26.Brouwers HB, Falcone GJ, McNamara KA, et al. CTA spot sign predicts hematoma expansion in patients with delayed presentation after intracerebral hemorrhage. Neurocrit Care. 2012;17:421鈥?.PubMed Central CrossRef PubMed 27.Rodriguez-Luna D, Rubiera M, Ribo M, et al. Serum low-density lipoprotein cholesterol level predicts hematoma growth and clinical outcome after acute intracerebral hemorrhage. Stroke. 2011;42:2447鈥?2.CrossRef PubMed 28.Kuramatsu JB, Mauer C, Kiphuth IC, et al. Reported antiplatelet use influences long-term outcome independently in deep intracerebral hemorrhage. Neurosurgery. 2012;70:342鈥?0.CrossRef PubMed 29.Silva Y, Leira R, Tejada J, Lainez JM, Castillo J, D谩valos A, Stroke Project, Cerebrovascular Diseases Group of the Spanish Neurological Society. Molecular signatures of vascular injury are associated with early growth of intracerebral hemorrhage. Stroke. 2005;36:86鈥?1.CrossRef PubMed 30.Rincon F, Lyden P, Mayer SA. Relationship between temperature, hematoma growth, and functional outcome after intracerebral hemorrhage. Neurocrit Care. 2013;18:45鈥?3.CrossRef PubMed 31.Yildiz OK, Arsava EM, Akpinar E, Topcuoglu MA. Previous antiplatelet use is associated with hematoma expansion in patients with spontaneous intracerebral hemorrhage. J Stroke Cerebrovasc Dis. 2012;21:760鈥?.CrossRef PubMed 32.Kazui S, Minematsu K, Yamamoto H, Sawada T, Yamaguchi T. Predisposing factors to enlargement of spontaneous intracerebral hematoma. Stroke. 1997;28:2370鈥?.CrossRef PubMed 33.Becker KJ, Baxter AB, Bybee HM, Tirschwell DL, Abouelsaad T, Cohen WA. Extravasation of radiographic contrast is an independent predictor of death in primary intracerebral hemorrhage. Stroke. 1999;30:2025鈥?2.CrossRef PubMed 34.Lim JK, Hwang HS, Cho BM, et al. Multivariate analysis of risk factors of hematoma expansion in spontaneous intracerebral hemorrhage. Surg Neurol. 2008;69:40鈥?.CrossRef PubMed 35.Huynh TJ, Demchuk AM, Dowlatshahi D, et al. PREDICT/Sunnybrook ICH CTA Study Group. Spot sign number is the most important spot sign characteristic for predicting hematoma expansion using first-pass computed tomography angiography: analysis from the PREDICT study. Stroke. 2013;44:972鈥?.CrossRef PubMed 36.Sullivan L, Massaro J, D鈥橝gostino R. Presentation of multivariate data for clinical use: the Framingham Study risk score functions. Stat Med. 2004;23:1631鈥?0.CrossRef PubMed 37.Lou M, Al-Hazzani A, Goddeau RP Jr, Novak V, Selim M. Relationship between white-matter hyperintensities and hematoma volume and growth in patients with intracerebral hemorrhage. Stroke. 2010;41:34鈥?0.CrossRef PubMed 38.Mart铆-F脿bregas J, Delgado-Mederos R, Granell E, RENEVAS group (Stroke Research Network, RETICS, Instituto de Salud Carlos III), et al. Microbleed burden and hematoma expansion in acute intracerebral hemorrhage. Eur Neurol. 2013;70:175鈥?.CrossRef PubMed 39.Feigin VL, Rinkel GJ, Lawes CM, et al. Risk factors for subarachnoid hemorrhage: an updated systematic review of epidemiological studies. Stroke. 2005;36:2773鈥?0.CrossRef PubMed 40.Kurth T, Kase CS, Berger K, Schaeffner ES, Buring JE, Gaziano JM. Smoking and the risk of hemorrhagic stroke in men. Stroke. 2003;34:1151鈥?.CrossRef PubMed 41.Finelli PF. Cerebral amyloid angiopathy as cause of convexity SAH in elderly. Neurologist. 2010;16:37鈥?0.CrossRef PubMed 42.Viswanathan A, Greenberg SM. Cerebral amyloid angiopathy in the elderly. Ann Neurol. 2011;70:871鈥?0.PubMed Central CrossRef PubMed
作者单位:Xiaoying Yao (1) (3) Ye Xu (2) Erica Siwila-Sackman (3) Bo Wu (3) (4) Magdy Selim (3)
1. Department of Neurology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, China 3. Stroke Division, Department of Neurology, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Palmer 127, Boston, MA, 02215, USA 2. Department of Global Health and Population, Harvard School of Public Health, Boston, MA, 02115, USA 4. Stroke Clinical Research Unit, Department of Neurology, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China
刊物主题:Internal Medicine; Neurology;
出版者:Springer US
ISSN:1556-0961
文摘
Background Identification of intracerebral hemorrhage (ICH) patients at risk of substantial hematoma expansion (SHE) could facilitate the selection of candidates likely to benefit from therapies aiming to minimize ICH growth. We aimed to develop a grading tool that can be quickly used during the hyperacute phase to predict the risk of SHE.